Wells Fargo’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-262
| Closed | – | – | 7070 |
|
|
2019
Q3 | $0 | Hold |
262
| – | – | ﹤0.01% | 7030 |
|
|
2019
Q2 | $0 | Hold |
262
| – | – | ﹤0.01% | 6870 |
|
|
2019
Q1 | $0 | Sell |
262
-203
| -44% | -$199 | ﹤0.01% | 6792 |
|
|
2018
Q4 | $0 | Hold |
465
| – | – | ﹤0.01% | 6881 |
|
|
2018
Q3 | $1K | Buy |
465
+1
| +0.2% | +$1 | ﹤0.01% | 6358 |
|
|
2018
Q2 | $0 | Buy |
464
+9
| +2% | +$3 | ﹤0.01% | 6853 |
|
|
2018
Q1 | $0 | Buy |
455
+1
| +0.2% | +$1 | ﹤0.01% | 6797 |
|
|
2017
Q4 | $0 | Buy |
454
+450
| +11,250% | +$517 | ﹤0.01% | 6780 |
|
|
2017
Q3 | $0 | Buy |
4
+1
| +33% | +$1 | ﹤0.01% | 6707 |
|
|
2017
Q2 | $0 | Sell |
3
-50
| -94% | -$57 | ﹤0.01% | 6734 |
|
|
2017
Q1 | $0 | Hold |
53
| – | – | ﹤0.01% | 6765 |
|
|
2016
Q4 | $0 | Buy |
53
+1
| +2% | +$1 | ﹤0.01% | 6705 |
|
|
2016
Q3 | $0 | Sell |
52
-24
| -32% | -$29 | ﹤0.01% | 6614 |
|
|
2016
Q2 | $0 | Sell |
76
-4
| -5% | -$5 | ﹤0.01% | 6692 |
|
|
2016
Q1 | $0 | Buy |
80
+76
| +1,900% | +$102 | ﹤0.01% | 6766 |
|
|
2015
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 6744 |
|
|
2015
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 6824 |
|
|
2015
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 6778 |
|
|
2015
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 6685 |
|
|
2014
Q4 | $0 | Sell |
4
-10
| -71% | -$34 | ﹤0.01% | 6750 |
|
|
2014
Q3 | $0 | Sell |
14
-187
| -93% | -$545 | ﹤0.01% | 6645 |
|
|
2014
Q2 | $0 | Buy |
201
+187
| +1,336% | +$517 | ﹤0.01% | 6586 |
|
|
2014
Q1 | $0 | Hold |
14
| – | – | ﹤0.01% | 6407 |
|
|
2013
Q4 | $0 | Hold |
14
| – | – | ﹤0.01% | 6298 |
|
|
2013
Q3 | $0 | Sell |
14
-2,596
| -99% | -$20K | ﹤0.01% | 6159 |
|
|
2013
Q2 | $19K | Buy |
+2,610
| New | +$18.9K | ﹤0.01% | 4893 |
|
Wells Fargo's CELGZ Position: Q4 2019 in Review
Wells Fargo sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q4 2019, closing a stake of 262 shares.
Wells Fargo first reported a position in CELGZ in Q2 2013 and held it in 26 quarters. The position peaked at $19K in Q2 2013. 0 funds tracked by Wall St. Rank hold CELGZ as of Q4 2019.
- Wells Fargo reported no remaining Celgene Corporation Contingent Value Rights position as of Q4 2019 after selling out during the quarter.
- Wells Fargo sold 262 Celgene Corporation Contingent Value Rights shares in Q4 2019.
- Wells Fargo first reported a position in Celgene Corporation Contingent Value Rights in Q2 2013 and held it in 26 quarters.
- Wells Fargo's Celgene Corporation Contingent Value Rights position peaked at $19K in Q2 2013.
- 0 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q4 2019.
Based on Wells Fargo's 13F filing for Q4 2019, filed 14 Feb 2020.